You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: November 28, 2023

Drug Sales Trends for KENALOG

✉ Email this page to a colleague

« Back to Dashboard

Drug Sales Revenue Trends for KENALOG
Drug Units Sold Trends for KENALOG

Annual Sales Revenues and Units Sold for KENALOG

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
KENALOG ⤷  Try a Trial ⤷  Try a Trial 2019
KENALOG ⤷  Try a Trial ⤷  Try a Trial 2018
KENALOG ⤷  Try a Trial ⤷  Try a Trial 2017
KENALOG ⤷  Try a Trial ⤷  Try a Trial 2016
KENALOG ⤷  Try a Trial ⤷  Try a Trial 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.